Clinical Trials in Massachusetts

Showing 6581-6600 of 13,570 trials

Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer

NCT02698891

This research study is testing the safety and feasibility of delivering the 4 cycles of 'dose-dense' paclitaxel without the use of Neulasta (Pegfilgrastim) as a Granulocyte Colony-stimulating Factor (G-CSF) support. The research study is for participants who have early stage breast cancer and have been recommended to receive a standard chemotherapy regimen, doxorubicin/cyclophosphamide (AC) plus Paclitaxel (T), in what is called a "dose-dense" fashion to prevent recurrences.

Early Stage Breast Cancer

Dana-Farber Cancer Institute127 participantsStarted Apr 2016

Boston, Massachusetts, United States • Milford, Massachusetts, United States • Weymouth, Massachusetts, United States +1 more locations

COMPLETEDPhase 1/226 miles

A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma

NCT02659020

The main purpose of this study is to evaluate the safety and efficacy of two anti-cancer drugs (gemcitabine and docetaxel) with and without the study drug known as olaratumab in participants with advanced soft tissue sarcoma (STS) or STS that has spread to another part(s) of the body.

Soft Tissue Sarcoma

Eli Lilly and Company310 participantsStarted Mar 2016

Santa Monica, California, United States • Aurora, Colorado, United States • Jacksonville, Florida, United States +45 more locations

Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer

A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma

Find Trials by Condition in Massachusetts

Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children

HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos

Hearing Loss and Communication Needs in a Group Care Setting for Older Adults

Post-Discharge Smoking Cessation Strategies: Helping HAND 4

Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

Phase 3 Extension Study of Dexpramipexole in ALS

NICU Parent Education Program

Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women

First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC

A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy

Diffusion MRI-1 Imaging Database

Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study

Imaging of Coronary Plaques in Participants Treated With Evolocumab

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

Gene Transfer Clinical Trial for Mucopolysaccharidosis (MPS) IIIB